Jazz Pharmaceuticals PLC at Jefferies London Healthcare Conference Transcript

Nov 14, 2023 / 12:30PM GMT
Akash Tewari - Jefferies LLC, Research Division - Equity Analyst

Good afternoon, everyone, day 1 London Healthcare Conference. Very factoring, we should have done a bigger room. Jazz is a hot ticket for sure. For those who don't know me, my name is Akash Tewari. I'm a pharma biotech analyst here at Jefferies, and I have the pleasure of hosting the Jazz Pharmaceuticals management team. Joining me today, and they will be giving some brief introductory remarks will be Renee Gala, President, Kelvin Tan, Chief Medical Officer; and then Samantha Pearce, Head of Europe and International. I'll give it -- I'll hand it over to you for some introductory remarks and we'll get started.

Renee D. Gala - Jazz Pharmaceuticals plc - President & COO

Sure. Yes. Okay. So just a reminder, we will be making forward-looking statements today. Please see our website and SEC filings for more information about our business. Should we refer to guidance, we're not updating or reiterating today. This is as of our earnings call last week. And then finally, should we refer to non-GAAP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot